Sorafenib-induced hepatic encephalopathy.
Marks, Anne-Bérengère
Sorafenib-induced hepatic encephalopathy. [electronic resource] - The Annals of pharmacotherapy Dec 2009 - 2121 p. digital
Publication Type: Case Reports; Letter
1542-6270
10.1345/aph.1M457 doi
Antineoplastic Agents--administration & dosage
Benzenesulfonates--administration & dosage
Carcinoma, Hepatocellular--drug therapy
Dose-Response Relationship, Drug
Hepatic Encephalopathy--chemically induced
Humans
Liver Neoplasms--drug therapy
Middle Aged
Niacinamide--analogs & derivatives
Phenylurea Compounds
Pyridines--administration & dosage
Sorafenib
Time Factors
Sorafenib-induced hepatic encephalopathy. [electronic resource] - The Annals of pharmacotherapy Dec 2009 - 2121 p. digital
Publication Type: Case Reports; Letter
1542-6270
10.1345/aph.1M457 doi
Antineoplastic Agents--administration & dosage
Benzenesulfonates--administration & dosage
Carcinoma, Hepatocellular--drug therapy
Dose-Response Relationship, Drug
Hepatic Encephalopathy--chemically induced
Humans
Liver Neoplasms--drug therapy
Middle Aged
Niacinamide--analogs & derivatives
Phenylurea Compounds
Pyridines--administration & dosage
Sorafenib
Time Factors